Metastatic Pancreatic Cancer: ASCO Guideline Update

New or updated recommendations for germline and somatic testing are provided for all treatment-eligible patients to select patients for recommended therapies, including pembrolizumab, olaparib, larotrectinib, or entrectinib, or potential clinical trials.

Journal of Clinical Oncology